knowledge -WSS

knowledge

author：Wikipedia 2025-08-12 09:08:19 - browse：5

This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

Hello, friends! I’m in San Francisco for the STAT Breakthrough Summit. Later today, I’ll be “fireside chatting” with Cytokinetics CEO Robert Blum. It’s not too late to join us virtually. Check out details here.

It’s a travel-shortened week for me, so in this newsletter, I decided to dive deep into PDS Biotech and its experimental drug for head and neck cancer. PDS is what I’d call a biotech cult stock.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Meta looks to target Twitter with a rival app called Threads

WSS

Option Care buys Amedisys in $3.6 billion home care deal

Medicare Advantage beneficiaries sue Humana over algorithm use

Why health care costs have stayed mostly flat since 2010

Editas, Vertex strike deal on CRISPR

Violet CEO on training clinicians to promote more inclusive care

7 people shot in DC, police say

explore

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

Jerome Adams on the need for new antivirals for Covid

Australia's humpback populations rebound raising hopes of marine scientists

After affirmative action ruling, medical educators look to 'holistic review'

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Tori Bowie and the unacceptable rates of Black maternal death

What STAT readers think about the FDA and patient advocacy

Medical leaders decry Supreme Court decision on affirmative action

Option Care buys Amedisys in $3.6 billion home care deal

Duchenne breakthrough therapy leaves behind pioneering families

Connecting traumatic brain injury and domestic violence

hotspot

Doctor appointment wait times are getting worse

CRISPR gene editing developments we’re watching in 2024

Prime Medicine, Myeloid Therapeutics clash over genome

PhRMA sues HHS over Medicare drug price negotiation

These geoengineering technologies could help combat the climate crisis, scientists say

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

focus

knowledge

hotspot

leisure time